Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8,710 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SGLT1 in pancreatic α cells regulates glucagon secretion in mice, possibly explaining the distinct effects of SGLT2 inhibitors on plasma glucagon levels.
Suga T, Kikuchi O, Kobayashi M, Matsui S, Yokota-Hashimoto H, Wada E, Kohno D, Sasaki T, Takeuchi K, Kakizaki S, Yamada M, Kitamura T. Suga T, et al. Among authors: yamada m. Mol Metab. 2019 Jan;19:1-12. doi: 10.1016/j.molmet.2018.10.009. Epub 2018 Oct 27. Mol Metab. 2019. PMID: 30416006 Free PMC article.
Hypothalamic SIRT1 prevents age-associated weight gain by improving leptin sensitivity in mice.
Sasaki T, Kikuchi O, Shimpuku M, Susanti VY, Yokota-Hashimoto H, Taguchi R, Shibusawa N, Sato T, Tang L, Amano K, Kitazumi T, Kuroko M, Fujita Y, Maruyama J, Lee YS, Kobayashi M, Nakagawa T, Minokoshi Y, Harada A, Yamada M, Kitamura T. Sasaki T, et al. Among authors: yamada m. Diabetologia. 2014 Apr;57(4):819-31. doi: 10.1007/s00125-013-3140-5. Epub 2013 Dec 29. Diabetologia. 2014. PMID: 24374551 Free PMC article.
Protection against high-fat diet-induced obesity in Helz2-deficient male mice due to enhanced expression of hepatic leptin receptor.
Yoshino S, Satoh T, Yamada M, Hashimoto K, Tomaru T, Katano-Toki A, Kakizaki S, Okada S, Shimizu H, Ozawa A, Tuchiya T, Ikota H, Nakazato Y, Mori M, Matozaki T, Sasaki T, Kitamura T, Mori M. Yoshino S, et al. Among authors: yamada m. Endocrinology. 2014 Sep;155(9):3459-72. doi: 10.1210/en.2013-2160. Epub 2014 Jul 8. Endocrinology. 2014. PMID: 25004093
A prospective randomized controlled study of long-term combination therapy using ursodeoxycholic acid and bezafibrate in patients with primary biliary cirrhosis and dyslipidemia.
Hosonuma K, Sato K, Yamazaki Y, Yanagisawa M, Hashizume H, Horiguchi N, Kakizaki S, Kusano M, Yamada M. Hosonuma K, et al. Among authors: yamada m. Am J Gastroenterol. 2015 Mar;110(3):423-31. doi: 10.1038/ajg.2015.20. Epub 2015 Mar 3. Am J Gastroenterol. 2015. PMID: 25732417 Clinical Trial.
Effect of dapagliflozin on colon cancer cell [Rapid Communication].
Saito T, Okada S, Yamada E, Shimoda Y, Osaki A, Tagaya Y, Shibusawa R, Okada J, Yamada M. Saito T, et al. Among authors: yamada m, yamada e. Endocr J. 2015;62(12):1133-7. doi: 10.1507/endocrj.EJ15-0396. Epub 2015 Oct 31. Endocr J. 2015. PMID: 26522271 Free article.
8,710 results